NHS roadmap to safely bring back routine operations during COVID-19
Health leaders have set out a series of measures to help local hospitals plan to increase routine operations and treatment, while keeping the necessary...
NHS Confederation launches NHS Reset campaign for a post COVID-19 NHS
The NHS Confederation has launched the NHS Reset campaign to contribute to the public debate on what the health and care system should look...
Mobile coronavirus testing units for frontline workers
Mobile coronavirus testing units, operated by the Armed Forces, will travel around the UK to increase access to coronavirus testing. Essential workers and the most...
Medicspot rolls out remote COVID-19 diagnosis system
Medicspot is rolling out the technology for remote COVID-19 diagnosis to protect staff and patients amid the COVID-19 outbreak. Working in partnership with clinical commissioning...
NICE coronavirus guidelines on gastrointestinal and liver conditions and acute myocardial injuries
NICE has published two new rapid coronavirus guidelines on the care of patients with suspected and confirmed COVID-19. They cover the management of disorders of...
New data shows varied state of haemophilia treatment around the world
To mark the 30th Anniversary of World Haemophilia Day, Sobi have released the 2020 Haemophilia Index which shows the varied state of haemophilia treatment...
Cegedim launches free pharmacist training during COVID-19
Cegedim launches free digital training to help pharmacists deliver ongoing care throughout COVID-19. Cegedim Rx, part of the innovative healthcare technology and services company, Cegedim,...
Advice on ibuprofen and coronavirus (COVID-19): Commission on Human Medicines
The Commission of Human Medicines (CHM) Expert Working Group on coronavirus (COVID-19) has given its advice on ibuprofen and coronavirus (COVID-19). It concluded that there is...
Interactive tool shows the science behind COVID-19 control measures
An online tool to illustrate the effects of different COVID-19 control measures has been developed by a team of University of Cambridge researchers. The ‘lowhighcovid’...
NICE COVID-19 guidelines for cystic fibrosis, COPD and dermatological conditions
NICE has published three more rapid guidelines on the care of patients with suspected and confirmed COVID-19, and in patients without COVID-19. They cover...
Latest articles
NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...
Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...
CMA formally concludes fludrocortisone investigation
The Competition and Markets Authority (CMA) has formally concluded its fludrocortison investigation and found that three pharmaceutical companies took part in an illegal arrangement...
MHRA response to Independent Medicines and Medical Devices Safety Review
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its response to the Independent Medicines and Medical Devices Safety Review. In its response, the...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
The ABPI Code & Virtual Promotional Meetings
As the pharma industry looks to virtual meetings and teams work remotely, what considerations are there around the ABPI Code and virtual promotional meetings? Whilst...
First Do No Harm: Independent Medicines and Medical Devices Safety Review publishes its recommendations
The Independent Medicines and Medical Devices Safety Review, chaired by Baroness Julia Cumberlege, has today published its report. Titled 'First Do No Harm', it comes...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...
Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...